Paul Zolkind

1.1k citations
33 papers · 440 indexed · h-index 13
Topics
Head and Neck Cancer Studies (15 papers)Cancer Immunotherapy and Biomarkers (9 papers)Cancer Diagnosis and Treatment (5 papers)

In The Last Decade

Paul Zolkind

27 papers receiving 434 citations

Peers

Paul Zolkind
Comparison fields: 5 of 50
  • Oncology 295
  • Immunology 136
  • Molecular Biology 134
  • Otorhinolaryngology 114
  • Pulmonary and Respiratory Medicine 102
Replace Marc Lucas Ooft with:
Marc Lucas Ooft Netherlands
Francesca Sparano Italy
Ravindra Uppaluri United States
Anke Van Lierop Germany
Monique C. de Jong Netherlands
Simone K. Bendtsen Denmark
Frank Ziemann Germany
Yae‐Eun Suh United Kingdom
Shiau-Chin Liu Taiwan
Patrick Chun United States
Paul Zolkind relative to Marc Lucas Ooft Netherlands Marc Lucas Ooft's profile →
Citations per field
00.5×1.5×2.4×
Marc Lucas Ooft · 1×
Citations per year

Countries citing papers authored by Paul Zolkind

Since Specialization
Citations

This map shows the geographic impact of Paul Zolkind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Zolkind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Zolkind more than expected).

Fields of papers citing papers by Paul Zolkind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Zolkind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Zolkind. The network helps show where Paul Zolkind may publish in the future.

Co-authorship network of co-authors of Paul Zolkind

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Zolkind. A scholar is included among the top collaborators of Paul Zolkind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Zolkind. Paul Zolkind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 0
5 0
6 2
7 2
8 4
9 1
10 5
11 15
12 4
13 3
14 8
15 18
16 57
17 23
18 35
19 35
20 20

About Paul Zolkind

Paul Zolkind is a scholar working on Otorhinolaryngology, Oncology and Periodontics, having authored 33 papers that have together received 440 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Otorhinolaryngology (114 citations), Oncology (295 citations) and Immunology (136 citations). Paul Zolkind has collaborated with scholars based in United States, Ireland and China. Frequent co-authors include Ravindra Uppaluri, Douglas R. Adkins, Tianxiang Lin, Gavin P. Dunn, Patrik Pipkorn, Glenn J. Hanna, Ryan S. Jackson, Malachi Griffith, Rebecca D. Chernock and Jason T. Rich. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026